450 russians with rare muscle disease to be tracked in real-world treatment study
NCT ID NCT07247279
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 4 times
Summary
This study watches how doctors in Russia treat adults with a rare muscle-weakening disease called generalized myasthenia gravis (gMG). It does not test any new drug. Instead, it collects information from medical records and routine check-ups for about 450 people over time. The goal is to understand which treatments are used and how patients do in everyday practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS (GMG) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGKazan', Russia
-
Research Site
RECRUITINGMoscow, Russia
-
Research Site
RECRUITINGNovosibirsk, Russia
-
Research Site
RECRUITINGRostov-on-Don, Russia
-
Research Site
RECRUITINGSaint Petersburg, Russia
-
Research Site
RECRUITINGSamara, Russia
-
Research Site
RECRUITINGUfa, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One-shot gene editor aims to correct a brain disorder at its source
- Hackathon for the undiagnosed: mayo clinic launches repository to crack rare disease cases
- Biobank aims to unlock genetic secrets of rare diseases
- AI could shorten the long road to a rare disease diagnosis
- New hope for kids with MVID: drug aims to cut diarrhea and IV needs
- Scientists launch study to map rare baker gordon syndrome from childhood to adulthood